Becton, Dickinson and Company logo

Becton, Dickinson and Company (BDX)

Market Closed
16 Oct, 08:00 PM
NYSE NYSE
$
191. 75
-2.01
-1.0374%
$
52.23B Market Cap
- P/E Ratio
4.2% Div Yield
1.41M Volume
- Eps
$ 193.76
Previous Close
Add Transaction
Day Range
190.21 195.99
Year Range
127.59 195.99
Want to track BDX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
4 Stocks to Buy Amid Dental Supplies Industry Challenges

4 Stocks to Buy Amid Dental Supplies Industry Challenges

Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These include BDX, MCK, COO and STAA.

Zacks | 2 years ago
BD Stock Rises as Neopak XtraFlow Syringe Expands in Biologics

BD Stock Rises as Neopak XtraFlow Syringe Expands in Biologics

BDX launches the Neopak XtraFlow Glass Prefillable Syringe, enhancing drug delivery for biologics and expanding capacity with new high-volume production lines.

Zacks | 2 years ago
Here's Why Becton Dickinson (BDX) is a Strong Value Stock

Here's Why Becton Dickinson (BDX) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 2 years ago
Here's Why Becton Dickinson (BDX) is a Strong Growth Stock

Here's Why Becton Dickinson (BDX) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 2 years ago
BD Stock Falls After Acquisition of Edwards' Critical Care Group

BD Stock Falls After Acquisition of Edwards' Critical Care Group

BDX expands its smart care portfolio by acquiring Edwards Lifesciences' Critical Care group, now BD Advanced Patient Monitoring, strengthening AI-driven health solutions.

Zacks | 2 years ago
Becton, Dickinson and Company (BDX) Wells Fargo 2024 Healthcare Conference

Becton, Dickinson and Company (BDX) Wells Fargo 2024 Healthcare Conference

Becton, Dickinson and Company (NYSE:BDX ) Wells Fargo 2024 Healthcare Conference September 4, 2024 8:45 AM ET Company Participants Tom Polen - Chairman, President & CEO Conference Call Participants Lawrence Biegelsen - Wells Fargo Lawrence Biegelsen Welcome back. Good morning.

Seekingalpha | 2 years ago
Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term

Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 2 years ago
Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term

Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 2 years ago
Why Becton Dickinson (BDX) is a Top Momentum Stock for the Long-Term

Why Becton Dickinson (BDX) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 2 years ago
The 3 Best Dividend Aristocrats to Buy for Sustainable Income: August 2024

The 3 Best Dividend Aristocrats to Buy for Sustainable Income: August 2024

Dividends have played a significant role in the total returns of equity investments. The practice of consistently increasing dividends can be seen in the S&P 500 Dividend Aristocrats.

Investorplace | 2 years ago
Becton, Dickinson And Company: Somewhat Undervalued, A Very Moderate Buy

Becton, Dickinson And Company: Somewhat Undervalued, A Very Moderate Buy

Becton, Dickinson is overwhelmingly considered undervalued by Wall Street analysts, with an average price target of ~$280 and highs of $312-$330. This is supported by my extensive DCF and comps models. BDX benefits from innovative products, strategic partnerships, and ongoing trends. The company boasts high margins and a reliable, growing dividend. However, the price is already pretty close to its all-time high and most price targets, so significant further appreciation is unlikely, making BDX a very moderate "Buy".

Seekingalpha | 2 years ago
BD (BDX) Q3 Earnings Surpass Estimates, Margins Expand

BD (BDX) Q3 Earnings Surpass Estimates, Margins Expand

BD's (BDX) overall topline benefits from revenue growth in all segments in the fiscal third quarter.

Zacks | 2 years ago
Loading...
Load More